Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report released on Saturday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

NYSE AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47. The company has a market capitalization of $2,497.00, a PE ratio of 0.00 and a beta of 3.67.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.